Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBM Psyence Biomedical Ltd

Not Yet Opened 02-03 16:00:00 EST

3.09

-0.71

-18.68%

盘后2.95

-0.14-4.47%

19:59 EST

High3.35	Low2.74	Vol548.01K
Open3.24	D1 Closing3.80	Amplitude16.02%
Mkt Cap3.16M	Tradable Cap3.00M	Total Shares1.02M
T/O1.67M	T/O Rate56.45%	Tradable Shares970.74K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":3.09,"timestamp":1770152400000,"preClose":3.8,"halted":0,"volume":548014,"hourTrading":{"tag":"盘后","latestPrice":2.9518,"preClose":3.09,"latestTime":"19:59 EST","volume":6662,"amount":19855.4468,"timestamp":1770166751580,"change":-0.1382,"changeRate":-0.044725,"amplitude":0.061489},"delay":0,"changeRate":-0.1868421052631579,"floatShares":970736,"shares":1022176,"eps":-13.15625,"marketStatus":"Not Yet Opened","change":-0.71,"latestTime":"02-03 16:00:00 EST","open":3.24,"high":3.3486,"low":2.74,"amount":1666423.768582,"amplitude":0.160158,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-13.15625,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770195600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":3.8,"preHourTrading":{"tag":"盘前","latestPrice":3.22,"preClose":3.8,"latestTime":"09:29 EST","volume":32462,"amount":105341.014364,"timestamp":1770128949625,"change":-0.58,"changeRate":-0.152632,"amplitude":0.113158},"postHourTrading":{"tag":"盘后","latestPrice":2.9518,"preClose":3.09,"latestTime":"19:59 EST","volume":6662,"amount":19855.4468,"timestamp":1770166751580,"change":-0.1382,"changeRate":-0.044725,"amplitude":0.061489},"volumeRatio":0.499172},"requestUrl":"/m/hq/s/PBM","defaultTab":"news","newsList":[{"id":"2608387661","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2608387661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608387661?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:45","pubTimestamp":1770122727,"startTime":"0","endTime":"0","summary":"Julong  shares were over 22% lower pre-bell Tuesday, erasing gains from the previous session.PayPal  stock was down 15% after the company reported Q4 non-GAAP earnings and revenue that trailed analysts' estimates.Psyence Biomedical  shares were 11% lower, adding to Monday's losses.Thomson Reuters  stock was down 10% after RBC cut its price target to $155 from $177.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4554","LU1668664300.SGD","LU2290526834.HKD","BK4227","BK4535","JLHL","LU1989763005.USD","IE00BQXX3C00.GBP","BK4588","BK4533","LU1861217088.USD","BK4106","BK4585","LU1989773731.SGD","PYPL","BK4129","BK4581","LU1861215975.USD","LU2089284900.SGD","BK4524","BK4598","LU2360107671.USD","BK4534","PYPY","BK4566","BK4139","PYPG","IE00BQXX3F31.USD","BK4527","LU2360107168.USD","LU1791807156.HKD","IE00BQXX3D17.EUR","LU2089283258.USD","PBM","BK7094","BK4551","LU1861220207.SGD","LU0158827948.USD","LU1861220033.SGD","LU0106831901.USD","TRI","LU2023251221.USD","BK4123","BK4579"],"gpt_icon":0},{"id":"2608416867","title":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:31 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608416867","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608416867?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:31","pubTimestamp":1770042696,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:31 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nAQN2LKANJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2608048140","title":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608048140","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608048140?lang=en_us&edition=fundamental","pubTime":"2026-02-01 16:28","pubTimestamp":1769934526,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nAQN2LK90T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2607507869","title":"Psyence Biomedical Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2607507869","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607507869?lang=en_us&edition=fundamental","pubTime":"2026-01-31 08:50","pubTimestamp":1769820626,"startTime":"0","endTime":"0","summary":"19:50 EST Psyence Biomedical (PBM) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2607721984","title":"Psyence Biomedical Announces 1-for-6.25 Reverse Stock Split Effective February 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2607721984","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607721984?lang=en_us&edition=fundamental","pubTime":"2026-01-29 07:30","pubTimestamp":1769643008,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has announced a 1-for-6.25 reverse stock split of its common shares, effective at the opening of the market on February 2, 2026. Following the consolidation, the shares will continue trading under the symbol \"PBM\" on the Nasdaq Capital Market with a new CUSIP number 74449F407. The consolidation will affect all shareholders uniformly, with minor adjustments for fractional shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL9pQFgQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","NDAQ","SG9999014005.SGD","BK4588","SG9999014013.SGD","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","BK4139","LU2210149790.SGD","LU0314104364.USD","BK4112","SG9999014021.USD","PBM","IE00BGHQF748.EUR","LU2210150020.SGD"],"gpt_icon":0},{"id":"2607072168","title":"Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2607072168","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607072168?lang=en_us&edition=fundamental","pubTime":"2026-01-29 07:30","pubTimestamp":1769643000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA9YMNL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2606921782","title":"Press Release: MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH","url":"https://stock-news.laohu8.com/highlight/detail?id=2606921782","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606921782?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:23","pubTimestamp":1769520180,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc.  , a leader in innovative healthcare technology, Pharmacy Benefit Management  and Third-Party Administration  services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings.Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy--a former HillCour portfolio company--which was acquired by Knipper in 2020. With a career spanning leadership roles in Pharmacy Benefit Management  and retail pharmacy operations, Davis brings a rare blend of operational rigor and innovative vision to the Marpai leadership team.\"MarpaiRx is at a pivotal inflection point, and we needed a leader who not only understands the complexities of the pharmacy landscape but knows how ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INC","MRAI","PBM","BK4173","BK4137","MIMI","BK4139"],"gpt_icon":0},{"id":"2605411389","title":"Press Release: Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411389","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605411389?lang=en_us&edition=fundamental","pubTime":"2026-01-23 02:42","pubTimestamp":1769107320,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 22, 2026  -- Psyence Biomedical Ltd.   today announced that it adjourned its annual and special meeting of shareholders  until February 12, 2026.The Meeting will now be held on February 12, 2026, at 9:00 a.m. New York Time/4:00 p.m. Cape Town time at Venture Workspace Riverlands, Office Building 4, Riverlands, 51 Gogosoa Street, Observatory, Cape Town, 7935, South Africa.The adjournment is a result of the requisite quorum of shareholders not having been achieved to hold the Meeting. The Company is working with its proxy agents to help ensure that quorum is obtained for the reconvened meeting on February 12, 2026. For details concerning the business of the Meeting, please see the Company's notice of meeting and management information circular dated January 2, 2026, filed on EDGAR. Please note that the record date for the Meeting, close of business on December 23, 2025, has not changed.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2604111641","title":"NASDAQ TRADE HALT CONTINUES  REASON NOT AVAILABLE AT 09:35 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111641","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604111641?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:35","pubTimestamp":1768919732,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  REASON NOT AVAILABLE AT 09:35 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nAQN2LID6O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2604118832","title":"Psyence BioMed Postpones Planned Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2604118832","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604118832?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:19","pubTimestamp":1768911586,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has postponed the effective date of its previously announced 1-for-6.25 reverse stock split. The company's Board of Directors will determine a new date for the share consolidation, and the stock will continue to trade on the Nasdaq Capital Market under the ticker symbol \"PBM\" until further notice.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL74cn1S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014013.SGD","SG9999014021.USD","LU2210149790.SGD","PBM","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","BK4139","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00B3QW5Z07.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2604902031","title":"Psyence Biomed Announces Postponement of Previously Announced Reverse Stock Split Effective Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2604902031","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604902031?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:19","pubTimestamp":1768911581,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA3XMQJK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2604910323","title":"Psyence Biomedical Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2604910323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604910323?lang=en_us&edition=fundamental","pubTime":"2026-01-17 08:50","pubTimestamp":1768611043,"startTime":"0","endTime":"0","summary":"19:50 EST Psyence Biomedical (PBM) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2604170199","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2604170199","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604170199?lang=en_us&edition=fundamental","pubTime":"2026-01-17 08:50","pubTimestamp":1768611000,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260117:nAQN2LI4OD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2603623802","title":"Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623802","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603623802?lang=en_us&edition=fundamental","pubTime":"2026-01-15 08:00","pubTimestamp":1768435200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nTUA9YGDYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2603642623","title":"Psyence BioMed Enacts 1-for-6.25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2603642623","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603642623?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:30","pubTimestamp":1768426258,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has announced a 1-for-6.25 reverse stock split of its issued and outstanding common shares, following a Board decision on December 4, 2025. The consolidation affects all shareholders uniformly, with fractional shares rounded according to standard procedures. Continental Stock Transfer & Trust Company is serving as the exchange and transfer agent for the process.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL3K9gzZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2602854812","title":"BRIEF-Psyence Biomed Approves 2026 Financial Strategy, Board Authorizes Share Buyback On Value Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2602854812","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602854812?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:33","pubTimestamp":1768224783,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomed Approves 2026 Financial Strategy, Board Authorizes Share Buyback On Value OpportunityJan 12 (Reuters) - Psyence Biomedical Ltd PBM.O:PSYENCE BIOMED APPROVES 2026 FINANCIAL STRATEG","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA2TMCPT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2602318625","title":"Psyence Biomedical Ltd. publishes MD&A report for year ended March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318625","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602318625?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:08","pubTimestamp":1767906499,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd., a vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics, provided a business update in its latest Management’s Discussion and Analysis. The company highlighted its position as the first life sciences biotechnology company focused on developing nature-derived psilocybin and ibogaine-based medicines to be listed on Nasdaq. Psyence Biomedical remains dedicated to addressing unmet mental health needs, particularly in palliative care, and continues to advance its evidence-based approach for the development of safe psychedelic medicines. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL40PlMx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2601882220","title":"Psyence BioMed Appoints Graham Patrick to Board as Christopher Bull Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2601882220","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601882220?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:15","pubTimestamp":1767622510,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. announced that Christopher Bull has resigned from its Board of Directors, effective December 1, 2025. Graham Patrick has been appointed to fill the resulting vacancy on the board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL1YYmzg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0314104364.USD","BK4112","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014021.USD","SG9999014013.SGD","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014039.USD","BK4139","SG9999014005.SGD","IE00BGHQF748.EUR","PBM"],"gpt_icon":0},{"id":"2601265882","title":"Press Release: Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2601265882","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601265882?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:15","pubTimestamp":1767622500,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 05, 2026  -- Psyence Biomedical Ltd.  , a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a significant scientific and manufacturing achievement.\"The successful production of GMP-compliant Ibogaine HCl represents an important advancement for Psyence BioMed and our vertically integrated strategy,\" said Jody Aufrichtig, Chief Executive Officer of Psyence BioMed. \"This achievement strengthens our manufacturing and quality capabilities and supports our long-term objective of advancing nature-derived psychedelic compounds through responsible, regulated development pathways.\". Psyence Biomedical Ltd.  is one of the few multi-asset, vertically integrated biopharmaceutical companies specializing in psychedelic-based therapeutics. It is the first life sciences biotechnology company focused on developing nature-derived  psilocybin and ibogaine-based psychedelic medicine to be listed on Nasdaq. We a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","BK4139","PBM"],"gpt_icon":0},{"id":"2592987061","title":"Correction: Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2592987061","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592987061?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:49","pubTimestamp":1766155771,"startTime":"0","endTime":"0","summary":"(Corrects the third paragraph to note the personal income and outlays report being rescheduled.)US stock futures were mixed in Friday's premarket session, with investors hopeful of a federal rate cut ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a9f9ae861e0d5137ca1db9f83a4575ef","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ISBC","UDOW","PBM","MYMmain","DOG","TSYW.SI","BK4585","BK4116","VMAR","DXD","QID","MNQmain","BK4547",".DJI","PSQ",".IXIC","NVIW.SI","DJX","BK4211","SQQQ","BK4007","WYFI","MGRT","USAW.SI","TQQQ","USJW.SI","SAVA","DDM",".SPX","SDOW","BK4588","BK4139","QLD","NQmain","YCBD","BK4190","HOPE"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.pacificbooker.bc.ca","stockEarnings":[{"period":"1week","weight":-0.2166},{"period":"1month","weight":-0.3812},{"period":"3month","weight":-0.8172},{"period":"6month","weight":-0.8817},{"period":"1year","weight":-0.9575},{"period":"ytd","weight":-0.3438}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.237918},{"month":2,"riseRate":0.4,"avgChangeRate":-0.225105},{"month":3,"riseRate":0.75,"avgChangeRate":0.142672},{"month":4,"riseRate":0.5,"avgChangeRate":-0.110088},{"month":5,"riseRate":0.5,"avgChangeRate":0.047065},{"month":6,"riseRate":0.75,"avgChangeRate":-0.123687},{"month":7,"riseRate":0.75,"avgChangeRate":0.230875},{"month":8,"riseRate":0.5,"avgChangeRate":-0.181154},{"month":9,"riseRate":0.75,"avgChangeRate":-0.153581},{"month":10,"riseRate":0.25,"avgChangeRate":-0.079288},{"month":11,"riseRate":0.25,"avgChangeRate":-0.211015},{"month":12,"riseRate":0.25,"avgChangeRate":-0.267978}],"exchange":"NASDAQ","name":"Psyence Biomedical Ltd","nameEN":"Psyence Biomedical Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Psyence Biomedical Ltd,PBM,Psyence Biomedical Ltd股票,Psyence Biomedical Ltd股票老虎,Psyence Biomedical Ltd股票老虎国际,Psyence Biomedical Ltd行情,Psyence Biomedical Ltd股票行情,Psyence Biomedical Ltd股价,Psyence Biomedical Ltd股市,Psyence Biomedical Ltd股票价格,Psyence Biomedical Ltd股票交易,Psyence Biomedical Ltd股票购买,Psyence Biomedical Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}